Challenging Racialized Narratives and Advancing Equitable Access in Ohio

Socioeconomic Determinants of Prostate Cancer Outcomes: Challenging Racialized Narratives and Advancing Equitable Access in Ohio

Author: Anton Joao‑Luz Allensworth, M.Ed.

Abstract

Prostate cancer mortality rates among African American men are frequently cited as evidence of racial predisposition. Emerging research, however, indicates that socioeconomic status, access to care, and timing of diagnosis are more predictive of outcomes. This review critically examines existing literature, including cohort studies of rural and Appalachian populations, and evaluates policy initiatives such as Ohio House Bill 33. It concludes with recommendations for healthcare providers and policymakers aimed at improving outreach and access for all men, regardless of race or income, with a particular focus on Ohio’s diverse communities.

Introduction

Prostate cancer is the second leading cause of cancer death among men in the United States. African American men are often reported to have the highest mortality rates, which has contributed to widespread assumptions of biological susceptibility. This narrative lacks nuance and fails to account for the roles of socioeconomic status, healthcare access, and systemic barriers in shaping outcomes. In states such as Ohio, where urban, rural, and Appalachian populations coexist, understanding these factors is essential for developing equitable public health strategies.

Racial Disparities in Context: The Role of Socioeconomic Status

Although African American men experience a higher incidence of aggressive prostate cancer, this disparity is largely attributable to late‑stage diagnosis and limited access to care. When socioeconomic status is controlled for, racial differences in outcomes diminish substantially. Men across all racial groups who have low incomes, limited insurance coverage, and poor access to healthcare facilities are less likely to receive timely screening and treatment.

A cohort study published in JAMA Network Open examined biochemical recurrence among 778 men with prostate cancer. Rural patients experienced a recurrence rate of 16.8 percent, compared to 8.5 percent among urban patients. Rural residence was independently associated with recurrence, with a hazard ratio of 1.74 and a 95 percent confidence interval of 1.07 to 2.82, even after adjusting for treatment type, health status, and National Comprehensive Cancer Network risk group. These findings highlight the significant impact of geographic and socioeconomic barriers on prostate cancer outcomes.

Appalachian Kentucky: A Mirror of Disparity

A population‑based study conducted by the University of Kentucky analyzed prostate cancer outcomes among men living in Appalachian Kentucky. Compared to their non‑Appalachian counterparts, these men presented with higher Gleason scores, more advanced disease at diagnosis, and lower rates of private insurance coverage. Despite being predominantly white, men in Appalachian Kentucky experienced survival outcomes similar to those often attributed to African American men. This reinforces the conclusion that socioeconomic status, rather than race, is a primary determinant of prognosis.

These findings are directly relevant to Ohio, which includes 32 counties designated as part of Appalachia. Many of these counties face overlapping challenges, including high poverty rates, limited healthcare infrastructure, and lower educational attainment. The similarities between Appalachian Kentucky and southeastern Ohio suggest that prostate cancer disparities in Ohio are not confined to racial lines but are rooted in deeper socioeconomic and geographic inequities.

Misinformation and Its Consequences

The prevailing narrative of racial predisposition can cause non‑Black men to underestimate their prostate cancer risk, particularly those from underserved communities. This misperception contributes to lower screening rates and delayed diagnoses. Additionally, attributing African American men’s hesitancy toward screening solely to historical mistrust, such as the Tuskegee Syphilis Study, oversimplifies the issue. Evidence suggests that inadequate health education, lack of insurance, and ineffective outreach are more significant barriers to screening.

Healthcare systems frequently fail to engage populations outside of African American communities, leaving rural white, Latino, and low‑income non‑Black men underserved or entirely unserved. Outreach efforts must be both inclusive and culturally competent. In Ohio, where metropolitan areas like Cleveland and Columbus exist alongside rural and Appalachian regions, a uniform approach to prostate cancer education and screening is insufficient.

Policy Landscape: Uneven Access to Care in Ohio

Ohio House Bill 33 mandates insurance coverage for preventive prostate cancer screening for men aged 40 years and older who are considered high risk, including those with a family history of prostate cancer or African American ancestry. While this legislation represents meaningful progress, its qualifying criteria may unintentionally reinforce racialized narratives and exclude other vulnerable populations, such as low‑income rural men who face comparable risks.

By contrast, Ohio House Bill 371 guarantees universal access to breast cancer screening for all women, regardless of age or individualized risk factors. This legislation removes barriers and promotes equitable access to preventive care. The contrast between HB 33 and HB 371 highlights a persistent gender‑based inequity within cancer prevention policy.

Section 1557 of the Affordable Care Act prohibits discrimination based on sex in federally funded health programs. In practice, however, ACA preventive care provisions have disproportionately benefited women. Services such as mammography and contraception are mandated, while equivalent coverage for prostate cancer screening remains inconsistent. This disparity leaves many men, particularly those without employer‑sponsored insurance, without access to potentially life‑saving preventive services.

Recommendations for Healthcare Providers and Policymakers

To reduce prostate cancer disparities, the following actions are recommended:

Policy Reform: Expand HB 33 to include all men aged 40 years and older, regardless of race or family history. Align prostate cancer screening mandates with those established for breast cancer to advance gender equity.

Healthcare Provider Engagement: Implement routine prostate cancer risk assessments for all male patients, with particular attention to those from underserved communities. Provide culturally competent education regarding risk factors and screening options.

Outreach and Access: Deploy mobile screening units in rural areas and low‑income urban neighborhoods, including Appalachian counties. Partner with trusted community organizations to promote awareness and facilitate testing.

Public Awareness Campaigns: Actively challenge misinformation related to racial predisposition. Promote inclusive messaging that emphasizes socioeconomic status and healthcare access as critical drivers of risk.

Community Engagement: Ensure outreach initiatives are visible, accessible, and well‑publicized. Programs cannot succeed if the populations they intend to serve are unaware of them.

Conclusion

Efforts to reduce prostate cancer disparities must move beyond race‑based assumptions and directly address structural determinants of health. Policy reform, community outreach, and provider education are all essential, but they are ineffective if intended populations remain uninformed or unable to access care. The Crowns Project, through its initiatives, is committed to ensuring that all men have access to early testing and appropriate treatment. By advancing equity in cancer care and engaging Ohio’s diverse communities, meaningful improvements in outcomes can be achieved for all men, regardless of race, income, or geography.